Evinacumab for Homozygous Familial Hypercholesterolemia

  • Agirbasli, Mehmet M.D.

No potential conflict of interest relevant to this letter was reported.

New England Journal of Medicine 384(6):p e17(1), February 11, 2021. | DOI: 10.1056/NEJMc2033612

Evinacumab for Homozygous Familial Hypercholesterolemia

  • Raal, Frederick J. M.D., Ph.D.
  • Rosenson, Robert S. M.D.
  • Reeskamp, Laurens F. M.D.
  • Hovingh, Kees G. M.D., Ph.D.
  • Kastelein, John J.P. M.D., Ph.D.
  • Rubba, Paolo M.D.
  • Ali, Shazia Pharm.D.
  • Banerjee, Poulabi Ph.D.
  • Chan, Kuo-Chen Ph.D.
  • Gipe, Daniel A. M.D.
  • Khilla, Nagwa M.S.
  • Pordy, Robert M.D.
  • Weinreich, David M. M.D.
  • Yancopoulos, George D. M.D., Ph.D.
  • Zhang, Yi Ph.D.
  • Gaudet, Daniel M.D., Ph.D.
New England Journal of Medicine 383(8):p 711-720, August 20, 2020. | DOI: 10.1056/NEJMoa2004215
Copyright © 2021 Massachusetts Medical Society. All rights reserved.
View full text|Download PDF